Your browser doesn't support javascript.
loading
Chemical Components in Hedera rhombea Leaves and Their Cytotoxicity.
Yokosuka, Akihito; Shimomura, Tatsuya; Yokogawa, Shohei; Oguro, Airi; Miyake, Katsunori; Mimaki, Yoshihiro.
Affiliation
  • Yokosuka A; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Shimomura T; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Yokogawa S; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Oguro A; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Miyake K; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
  • Mimaki Y; School of Pharmacy, Tokyo University of Pharmacy and Life Sciences.
Chem Pharm Bull (Tokyo) ; 70(2): 175-181, 2022.
Article in En | MEDLINE | ID: mdl-35110439
ABSTRACT
Two novel triterpene glycosides (1 and 2), 17 known triterpene glycosides (3-19), two known flavonoid glycosides (20 and 21), and two known norsesquiterpene glucosides (22 and 23) were isolated from Hedera rhombea (Araliaceae) leaves. The structures of 1 and 2 were determined by spectroscopic analysis, including two-dimensional NMR spectroscopy, and chromatographic analysis of the hydrolyzed products. The cytotoxicity of the isolated triterpene glycosides (1-19) against HL-60 human promyelocytic leukemia cells was evaluated. Compounds 9, 10, and 11 were cytotoxic to HL-60 cells with IC50 values of 7.2, 21.9, and 32.8 µM, respectively. Other compounds isolated from the leaves were not cytotoxic at sample concentrations of 50 µM.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triterpenes / Plant Leaves / Araliaceae / Glycosides / Antineoplastic Agents, Phytogenic Limits: Humans Language: En Journal: Chem Pharm Bull (Tokyo) Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Triterpenes / Plant Leaves / Araliaceae / Glycosides / Antineoplastic Agents, Phytogenic Limits: Humans Language: En Journal: Chem Pharm Bull (Tokyo) Year: 2022 Document type: Article